Cargando…
Optical Coherence Tomography Biomarkers of Inflammation in Diabetic Macular Edema Treated by Fluocinolone Acetonide Intravitreal Drug-Delivery System Implant
INTRODUCTION: The fluocinolone acetonide (FAc) intravitreal drug-delivery system implant is a recent, second-line, intravitreal drug for the management of diabetic macular edema (DME). FAc acts against DME with a major anti-inflammatory effect. Despite the already proved efficacy, a number of patien...
Autores principales: | Arrigo, Alessandro, Capone, Luigi, Lattanzio, Rosangela, Aragona, Emanuela, Zollet, Piero, Bandello, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708540/ https://www.ncbi.nlm.nih.gov/pubmed/32914324 http://dx.doi.org/10.1007/s40123-020-00297-z |
Ejemplares similares
-
Foveal Eversion: A Possible Biomarker of Persistent Diabetic Macular Edema
por: Arrigo, Alessandro, et al.
Publicado: (2021) -
Intraocular Pressure Changes Are Predictive of Ocular Hypertension Onset After Fluocinolone Acetonide Implant: Significant Cutoffs and the Role of Previous DEX Implant
por: Arrigo, Alessandro, et al.
Publicado: (2021) -
Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema
por: Messenger, Wyatt B, et al.
Publicado: (2013) -
Foveal eversion patterns in diabetic macular edema
por: Arrigo, Alessandro, et al.
Publicado: (2022) -
Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant
por: Baillif, Stéphanie, et al.
Publicado: (2022)